Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Tracking-seq reveals the heterogeneity of off-target effects in CRISPR–Cas9-mediated genome editing

Abstract

The continued development of novel genome editors calls for a universal method to analyze their off-target effects. Here we describe a versatile method, called Tracking-seq, for in situ identification of off-target effects that is broadly applicable to common genome-editing tools, including Cas9, base editors and prime editors. Through tracking replication protein A (RPA)-bound single-stranded DNA followed by strand-specific library construction, Tracking-seq requires a low cell input and is suitable for in vitro, ex vivo and in vivo genome editing, providing a sensitive and practical genome-wide approach for off-target detection in various scenarios. We show, using the same guide RNA, that Tracking-seq detects heterogeneity in off-target effects between different editor modalities and between different cell types, underscoring the necessity of direct measurement in the original system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Tracking-seq: a universal assay for off-target detection via tracking common DNA damage repair protein RPA.
Fig. 2: The performance of Tracking-seq for assessing the genome-wide specificity of Cas9.
Fig. 3: Tracking-seq assesses the genome-wide specificity of CBE, ABE and PEs.
Fig. 4: Tracking-seq applied to ex vivo and in vivo editing.
Fig. 5: Heterogeneity of off-target effects when using different genome-editing tools.
Fig. 6: Heterogeneity of off-target effects among different cell types.

Similar content being viewed by others

Data availability

Tracking-seq data have been deposited in the National Center for Biotechnology Informationʼs Gene Expression Omnibus with accession number GSE236360 (ref. 51). Source data are provided with this paper. All other data are available in the Supplementary Information.

Code availability

Code for Tracking-seq analysis is available on GitHub (https://github.com/Lan-lab/offtracker)52.

References

  1. Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229–236 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806–2827 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136–150 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kim, D., Luk, K., Wolfe, S. A. & Kim, J.-S. Evaluating and enhancing target specificity of gene-editing nucleases and deaminases. Annu. Rev. Biochem. 88, 191–220 (2019).

    Article  CAS  PubMed  Google Scholar 

  5. Tao, J., Bauer, D. E. & Chiarle, R. Assessing and advancing the safety of CRISPR–Cas tools: from DNA to RNA editing. Nat. Commun. 14, 212 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kim, D. et al. Digenome-seq: genome-wide profiling of CRISPR–Cas9 off-target effects in human cells. Nat. Methods 12, 237–243 (2015).

    Article  CAS  PubMed  Google Scholar 

  7. Cameron, P. et al. Mapping the genomic landscape of CRISPR–Cas9 cleavage. Nat. Methods 14, 600–606 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. Tsai, S. Q. et al. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets. Nat. Methods 14, 607–614 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR–Cas nucleases. Nat. Biotechnol. 33, 187–197 (2015).

    Article  CAS  PubMed  Google Scholar 

  10. Wienert, B. et al. Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science 364, 286–289 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Zou, R. S. et al. Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+. Nat. Methods 20, 706–713 (2023).

  12. Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S. & Gregory, P. D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636–646 (2010).

    Article  CAS  PubMed  Google Scholar 

  13. Joung, J. K. & Sander, J. D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14, 49–55 (2013).

    Article  CAS  PubMed  Google Scholar 

  14. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020).

    Article  CAS  PubMed  Google Scholar 

  16. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Liu, T. & Huang, J. Replication protein A and more: single-stranded DNA-binding proteins in eukaryotic cells. Acta Biochim Biophys. Sin. 48, 665–670 (2016).

    Article  CAS  PubMed  Google Scholar 

  20. Wold, M. S. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61–92 (1997).

    Article  CAS  PubMed  Google Scholar 

  21. Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006–1019 (2018).

    Article  CAS  PubMed  Google Scholar 

  22. Kabeche, L., Nguyen, H., Buisson, R. & Zou, L. A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation. Science 359, 108–114 (2018).

  23. Gan, X. et al. Proper RPA acetylation promotes accurate DNA replication and repair. Nucleic Acids Res. 51, 5565–5583 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ferrari, M., Twayana, S., Marini, F. & Pellicioli, A. In Genome Instability: Methods and Protocols (eds Muzi-Falconi, M. & Brown, G. W.) 119–129 (Humana Press, 2017).

  26. Stoler, N. & Nekrutenko, A. Sequencing error profiles of Illumina sequencing instruments. NAR Genom. Bioinform. 3, lqab019 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kim, D., Kim, S., Kim, S., Park, J. & Kim, J.-S. Genome-wide target specificities of CRISPR–Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res. 26, 406–415 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lei, Z. et al. Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors. Nat. Methods 18, 643–651 (2021).

    Article  CAS  PubMed  Google Scholar 

  29. Liang, P. et al. Genome-wide profiling of adenine base editor specificity by EndoV-seq. Nat. Commun. 10, 67 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Liang, S.-Q. et al. Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag. Nat. Methods 20, 898–907 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kim, D. Y., Moon, S. B., Ko, J.-H., Kim, Y.-S. & Kim, D. Unbiased investigation of specificities of prime editing systems in human cells. Nucleic Acids Res. 48, 10576–10589 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Zuo, E. et al. Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science 364, 289–292 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Duan, J. et al. Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell Res. 24, 1009–1012 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Frangoul, H. et al. CRISPR–Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384, 252–260 (2021).

    Article  CAS  PubMed  Google Scholar 

  35. Nakamura-Ishizu, A., Takizawa, H. & Suda, T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141, 4656–4666 (2014).

    Article  CAS  PubMed  Google Scholar 

  36. Chang, H. H. Y., Pannunzio, N. R., Adachi, N. & Lieber, M. R. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18, 495–506 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wienert, B., Wyman, S. K., Yeh, C. D., Conklin, B. R. & Corn, J. E. CRISPR off-target detection with DISCOVER-seq. Nat. Protoc. 15, 1775–1799 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wheeler, D. L. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 33, D39–D45 (2005).

    Article  CAS  PubMed  Google Scholar 

  39. Zhang, H. et al. Fast alignment and preprocessing of chromatin profiles with Chromap. Nat. Commun. 12, 6566 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Kent, W. J., Zweig, A. S., Barber, G., Hinrichs, A. S. & Karolchik, D. BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics 26, 2204–2207 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bleckwehl, T. et al. Enhancer-associated H3K4 methylation safeguards in vitro germline competence. Nat. Commun. 12, 5771 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Man, N. et al. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia. JCI Insight 6, e138478 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  47. Ji, L. et al. TOPORS, a tumor suppressor protein, contributes to the maintenance of higher-order chromatin architecture. Biochim. Biophys. Acta Gene Regul. Mech. 1863, 194518 (2020).

    Article  CAS  PubMed  Google Scholar 

  48. Lex, R. K. et al. GLI transcriptional repression regulates tissue-specific enhancer activity in response to Hedgehog signaling. eLife 9, e50670 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Boix, C. A., James, B. T., Park, Y. P., Meuleman, W. & Kellis, M. Regulatory genomic circuitry of human disease loci by integrative epigenomics. Nature 590, 300–307 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224–226 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Zhu, M. et al. Tracking-seq reveals the heterogeneity of off-target effects in CRISPR/Cas9-mediated genome editing. NCBI https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE236360 (2024).

  52. Xu, R. Offtracker. GitHub https://github.com/Lan-lab/offtracker (2024).

Download references

Acknowledgements

We thank H. Ren and T. Wei (Institute of Zoology, Chinese Academy of Sciences) for their help with mouse liver delivery. We thank W. Shao and H. Qi (School of Medicine, Tsinghua University) for providing mouse B cells. This work was partially supported by grants from the National Natural Science Foundation of China (grant no. 81972680 to X. Lan), the Beijing Natural Science Foundation (grant no. Z210010 to Y.L.), the Tsinghua University-Peking University Joint Center for Life Science (grant no. 61020100119 to X. Lan), the Beijing Natural Science Foundation (grant no. 20201100463 to X. Lan), the Tsinghua University Initiative Scientific Research Program (grant no. 2022Z11QYJ032 and grant no. 2021Z11JCQ020 to Y.L.), the National Natural Science Foundation of China (grant no. 32171448 to Y.L.) and the National Key R&D Program of China (grant no. 2019YFA0904402 and grant no. 2019YFA0906700 to Y.L.) M.Z. is supported by a Tsinghua-Peking Center for Life Sciences postdoctoral fellowship.

Author information

Authors and Affiliations

Authors

Contributions

M.Z., Y.L. and X. Lan designed the study and experiments. M.Z. and J.W. developed the Tracking-seq experimental protocol. M.Z., J.W. and Y.Y. conducted Tracking-seq experiments. R.X. developed the algorithm for analyzing Tracking-seq data and analyzed all sequencing data. J.Y. and M.Z. conducted genome editing on cell lines. T.C. conducted genome editing on mHSPCs. J.Y., M.Z. and A.J. conducted genome editing on mouse liver. R.X., X.R., J.Y. and H.T. conducted targeted amplicon sequencing. H.W., P.Z., J.D. and X. Lin helped with the delivery into mouse livers. H.Y. and C.L. participated in discussions. X. Lan, Y.L. and W.X. supervised the experiments. M.Z., R.X., Y.L. and X. Lan wrote the manuscript.

Corresponding authors

Correspondence to Ming Zhu, Yinqing Li or Xun Lan.

Ethics declarations

Competing interests

Tsinghua University has submitted a patent application (PCT/CN2023/071055) on the method for off-target detection used in this study, with M.Z., Y.L. and X. Lan as inventors. The remaining authors declare no competing interests.

Peer review

Peer review information

Nature Biotechnology thanks the anonymous reviewers for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Highly distinguishable signals produced by Tracking-seq.

a, The DNA cleavage sites were located at the center of symmetry of the Tracking-seq signal. b, Boxplot showing the signal lengths of different editing tools at different time points after transfection with HEK293_site_4 (n = 1 for each condition). Each dot indicates an editing site. Top 10 sites were shown for Cas9, ABE, and CBE; All 5 positive sites were shown for PE2. Boxplot format: center line: median; box limits: quartiles; whiskers: 1.5 × interquartile range (IQR). c, Boxplot showing the signal intensity bias of different editing tools for HEK293_site_4 and VEGFA_site_2 (n = 1 for each condition). Cas9 signals showed no bias while BEs and PEs signals tended to enrich in non-nicked strands. The non-nicked strands of BEs are the PAM-containing strands while those of PEs are the opposite of PAM-containing strands. Each dot indicates an editing site. P-values were calculated by the one-sided Wilcoxon rank-sum test. Boxplot format: center line: median; box limits: quartiles; whiskers: 1.5 × interquartile range (IQR). d, The schematic diagram illustrates a quantitative method for determining the relative proportion of single-stranded DNA (ssDNA) upstream and downstream of the editing site. Two restriction enzyme sites equidistant from the cleavage site of the editing site were selected. qPCR primers were designed near the enzyme cutting sites to allow for binding of upstream and downstream primers on either side of the cleavage site. Genomic DNA from editing cells was digested using the corresponding restriction enzyme. Double-stranded DNA containing the enzyme cutting sites near the editing site was cleaved, while ssDNA remained intact for qPCR amplification. By normalizing the qPCR cycle threshold (Cq) values to those of the corresponding genomic positions in wild-type (WT) cells, the relative quantities of ssDNA upstream and downstream of the editing site were quantified. e, Boxplot showing the relative quantities of ssDNA 1 kb upstream and downstream of the on-target site of HEK293_site_4. ABE and PE2 showed more ssDNA in the upstream regions, which suggested ssDNA was enriched in the PAM-containing strand for both ABE and PE2 at the on-target site. Three technical replicates were performed for each condition. Error bars indicate ± SD. f, Correlation of off-target Track scores in experiments using 200,000 cells (left) or 5,000 cells (right) compared to those obtained with 500,000 cells. Each dot represents an off-target site. g, Tracking-seq signals at two off-target sites with different initial numbers of pure GFP+ cells (dark blue tracks) or cells mixing varying numbers of GFP+ cells with wild-type (WT) cells up to a total of 100,000 cells through a gradient dilution (light blue tracks). h, Track scores and corresponding indel rates obtained from different proportions of GFP+ cells through the gradient dilution (100,000 cells in total). Blue bars and the left y-axis indicate the Track score; red dots, percentage numbers, and the right y-axis indicate the indel rate; the dashed line indicates the threshold of the Track score for positive sites.

Source data

Extended Data Fig. 2 Dynamics of Tracking-seq signal over time for HEK293T with sgRNA HEK293_site_4.

a, The signal of the on-target site and an off-target site were shown. The condition is 500, 000 HEK293T cells with sgRNA HEK293_site_4. b, The dynamics of Tracking-seq signals over time (n = 1 for each condition). The time points indicate the periods after the PEI transfection of HEK293T cells. Background indicates the mean score of all negative sites (see Methods for more details). c, The expression kinetics of editing proteins (left) and guide RNAs (right) measured by the fluorescent intensity at different time points after transfrection. (n = 1 for each condition).

Source data

Extended Data Fig. 3 Comparison of the number of editing sites detected by Tracking-seq and GUIDE-seq.

a, Venn diagrams comparing Cas9-induced editing sites detected by Tracking-seq with those detected by GUIDE-seq for 9 different sgRNAs. b, The number of detected editing sites of Tracking-seq and GUIDE-seq were highly correlated. Each dot indicates a sgRNA. ρ indicates Spearman’s rank correlation coefficients.

Source data

Extended Data Fig. 4 Performance evaluation of four off-target detection methods with HEK293T cells edited by Cas9 and HEK293_site_4 or VEGFA_site_2.

a, The numbers of detected off-target sites from HEK293T cells edited with Cas9 and HEK293_site_4 (left) or VEGFA_site_2 (right) in this study were comparable to those detected by Zou et al. Nat. Methods 2023. b, Boxplot showing the distribution of Track scores, DISCOVER scores, DISCOVER+ scores, and GUIDE scores among different indel ranges for HEK293_site_4 and VEGFA_site_2 (n = 1 for each condition). Each dot indicates a site tested by amplicon sequencing. Fractional numbers in blue indicate true-positive proportion and those in red indicate false-positive proportion. c, Comparisons of Track scores and scores from three other methods for HEK293_site_4 and VEGFA_site_2. Each dot indicates a site from the pool of collected candidate off-target sites. ρ indicates Spearman’s rank correlation coefficients.

Extended Data Fig. 5 Genome tracks of representative off-target sites.

a-b, Signals generated by Tracking-seq, DISCOVER-seq, and DISCOVER-seq+ at representative off-target sites for HEK293_site_4 (a) and VEGFA_site_2 (b). ‘+’ or ‘-’ under the ‘Detection’ columns indicates whether the site was detected or not by the corresponding method. The indel rates shown below the tracks were measured by amplicon sequencing. c, Signals at off-target sites with indel <0.01% but showing the distinct Tracking-seq pattern for HEK293_site_4 (left) and VEGFA_site_2 (right). Rep1 and rep2 were two biological replicates. WT HEK293T cells were used as control.

Extended Data Fig. 6 CBE, CBE-dCas9, and PE2 edited with HEK293_site_4.

a-b, Bar chart shows the C-to-T rates of all tested sites detected by Tracking-seq (a) and not detected by Tracking-seq (b). Cytosines upstream of the protospacer, cytosines within the protospacer, indels, and background cytosines are in blue, pink, purple, and grey, respectively. Background refers to cytosines located outside the protospacer but within ±50 bp from the 5′ end of the protospacer. Two technical replicates were performed for each site. Bars with one point and no error bar indicates PCR failures for one of the two replicates. Error bars indicate ± SD. c, The editing efficiency of CBE with dCas9 at the on-target site of HEK293_site_4, showing ~23% C to T conversion in the editing window. d, Tracking-seq signals at the on-target site. e, Comparison of the Track scores of CBE with nCas9 and CBE with dCas9. Each dot represents a candidate off-target site; the dashed line indicates the threshold for positive sites. f, Tracking-seq signals at a representative off-target site. g, Bar charts showing editing rates of off-target sites induced by PE2 detected by Tracking-seq. Dots in the bar charts indicate biological replicates. Precise editing refers to sequence changes that exactly match the reverse transcriptase template at the on-target site. All the other mutations fall into ‘undesirable substitution’ or ‘undesirable indel’. h, Sequences related to Off-2 with unusually high indel rates in g. The last four rows indicate representative sequences detected in the amplicon sequencing.

Source data

Extended Data Fig. 7 Track-seq signals around on-target and off-target sites of PE editing.

Samples were HEK293T cells edited by PE2-HEK293_site_4, PE2-VEGFA_site_2, or PE3-VEGFA_site_2.

Extended Data Fig. 8 Cas9-biased off-target sites of HEK293_site_4.

a-b, Genomic sequences of off-target sites with high Track scores in Cas9 editing but low Track scores in CBE editing (a) or ABE editing (b). The coordinates in red are sites tested by amplicon sequencing (related to Fig. 5c and Fig. 5e).

Extended Data Fig. 9 Comparison of track scores in different conditions.

a, Consistency of Tracking-seq between replicates. Batch1 and batch2 were two biological replicates while batch2_1 and batch2_2 were two technical replicates. The condition is 500, 000 HEK293T cells with sgRNA HEK293_site_4 after 96-hour Cas9 editing. Each dot indicates a candidate site. b, Comparison of track scores between PE2 and PE3 using VEGFA_site_2 in HEK293T cells. c, Comparison of track scores between 150, 000 cells and 60, 000 cells of mHSPCs with Cas9 editing using Pcsk9-gP+G. d, Comparison of track scores among mHSPCs, mESCs, NIH3T3 cells, and AML12 cells with Cas9 editing using Pcsk9-gP+G. For mHSPCs, the mean track score of the two experiments (150, 000 cells and 60, 000 cells) was used. For mESCs, one experiment of 30,000 cells was conducted. For NIH3T3, the mean track score of the two experiments (100, 000 cells and 200, 000 cells) was used. For AML12, one experiment of 100,000 cells was conducted. The orange dots and red dots represent the tested differential off-target sites (the same as Fig. 6a).

Source data

Extended Data Fig. 10 Heterogeneity of off-target sites.

a, Scatter plots showing the correlation between Track scores and indel rates of 4 cell types at 7 differential off-target sites. b, The wild-type genome sequences of NIH3T3 cells, AML12 cells, mHSPCs, and mESCs around tested off-target sites. Dots in the bar charts indicate biological replicates. c, Indel rates and Track scores of the off-target sites Dif-04 to Dif-07 in four cell types and their ATAC-seq, H3K9me3 ChIP-seq, and H3K27ac ChIP-seq signals. Dots in the bar charts indicate biological replicates. d, Enrichment of epigenetic profiles around off-target sites of Pcsk9-gP+G in NIH3T3 cells, AML12 cells, mHSPCs, and mESCs.

Supplementary information

Supplementary Information

Supplementary Figs. 1–10, Tables 1–4 and methods.

Reporting Summary

Supplementary Table 5

Sequences of sgRNAs and pegRNAs.

Supplementary Table 6

Comprehensive results of four methods.

Supplementary Table 7

Other Tracking-seq and amplicon results for human.

Supplementary Table 8

Tracking-seq and amplicon results for mouse.

Supplementary Table 9

All primer sequences.

Source data

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, M., Xu, R., Yuan, J. et al. Tracking-seq reveals the heterogeneity of off-target effects in CRISPR–Cas9-mediated genome editing. Nat Biotechnol 43, 799–810 (2025). https://doi.org/10.1038/s41587-024-02307-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41587-024-02307-y

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research